The first 10 drugs selected for Medicare price negotiations now have new prices set to take effect in 2026. Industry observers note that most of these drugs are older products facing generic competition soon, so greater industry impact will come as the program expands to more drugs in years to come.
The post CMS Touts First Negotiated Drug Prices, But Greater Impact Expected In Future Rounds appeared first on Above the Law.
